π Tender Overview
In accordance with article 57(1) and (2) of Regulation EU 2019/6 and with the specific requirements set in Commission Delegated Regulation EU 2021/578 and Commission Implementing Regulation EU 2022/209, MS are to collect relevant and comparable data on the volume on sales on Veterinary Antimicrobial medicinal products and on the use of antimicrobial medicinal products used in animals per animal species, and to report collated data to the European Medicines Agency (EMA). Having efficient data collection systems set in place in due time in the MS is crucial to monitor progress towards the achievement of the Farm-to-Fork strategy objective to reduce overall EU sales of antimicrobials used for farmed animals and in aquaculture by 50% by 2030. Furthermore, the identification of relevant trends in the volume of sales of veterinary antimicrobial medicinal products and in the use of antimicrobial medicinal products per animal species at national and union level place an essential role in supporting the development of targeted measures to find antimicrobial resistance and in monitoring their effect. Setting up or developing data collection systems on the use of antimicrobial medicinal products per animal species in line with Regulation EU 2019/6 and with the specific requirements set in Commission Delegated Regulation EU 2021/578 will require sizeable efforts from MS